July 08, 2026 a 08:38 pm
CRL: Analysts Ratings - Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. operates as a vital contract research organization, providing pivotal preclinical services globally. With a steady emphasis on diverse market offerings, the company's stock has seen mixed sentiment from analysts, reflecting the evolving dynamics of the pharmaceutical and biotechnology sectors it serves. Strong Buy and Buy ratings persist as dominant, showcasing a fundamental confidence in its long-term prospects.
Historical Stock Grades
The latest analyst recommendations for Charles River Laboratories point towards a moderately positive market sentiment. The predominant ratings are Strong Buy and Buy, illustrating a significant degree of confidence among analysts.
| Recommendation | Number | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 10 | |
| Hold | 2 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
Analyst ratings for Charles River Laboratories have shown dynamic shifts over recent months. A notable trend is the heightened interest reflected in Strong Buy ratings over time alongside a steady Buy interest.
- Overall ratings have increased from the previous months, indicating stronger market optimism.
- There is a visible reduction in the Hold and Strong Sell categories, suggesting fewer neutral or negative outlooks.
- Buy ratings have remained consistently high, underscoring persistent confidence in growth potential.
Percentage Trends
In recent months, the percentage of Strong Buy and Buy ratings has seen fluctuations but remains largely positive. This dynamic reflects a shift in analyst sentiment towards increased optimism about the company's prospects.
- Strong Buy and Buy ratings constitute a majority of the recommendations, accounting for over 76% combined in the latest data.
- Hold ratings have gradually decreased as confidence levels improve.
- The minimal Sell and Strong Sell suggestions indicate a low level of bearish sentiment.
- Over the past year, Strong Buy recommendations increased by 100%, reflecting a growing positive outlook.
Latest Analyst Recommendations
The most recent analysis shows a positive evolution in the assessment of Charles River Laboratories. A prominent shift from Hold to Outperform signals enhancing confidence from key financial institutions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-17 | Overweight | Equal Weight | Morgan Stanley |
| 2026-05-29 | Outperform | Hold | CLSA |
| 2026-05-08 | Overweight | Overweight | Barclays |
| 2026-05-08 | Outperform | Outperform | Evercore ISI Group |
| 2026-04-14 | Overweight | Overweight | Barclays |
Analyst Recommendations with Change of Opinion
Recent months illustrate a distinct trend in opinion shift among analysts for Charles River Laboratories. Multiple upgrades reflect a rejuvenated sense of optimism across various financial institutions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-17 | Overweight | Equal Weight | Morgan Stanley |
| 2026-05-29 | Outperform | Hold | CLSA |
| 2025-11-06 | Outperform | Neutral | Baird |
| 2025-10-06 | Outperform | Market Perform | William Blair |
| 2025-10-02 | Overweight | Equal Weight | Barclays |
Interpretation
Market sentiment towards Charles River Laboratories stock indicates a robust confidence in its future growth potential. The dominance of Strong Buy and Buy ratings suggests analysts view the company as well-positioned within its industry. Recent upgrades from prominent financial institutions further reaffirm this positivity, reflecting heightened trust in the company's strategic actions and market position. While the stability of these opinions remains generally steady, the observed shifts towards more optimistic recommendations hint at increasing optimism, albeit with caution in volatile sectors.
Conclusion
The current analysis of Charles River Laboratories International, Inc. provides insight into its resilient market position within the contract research sector. Analysts largely support a positive outlook, as seen by the prevalence of Strong Buy and Buy ratings. While there are risks concerning industry dynamics and macroeconomic factors, Charles River appears to be a stable investment with signs of upward momentum. The evolving sentiment marks a significant opportunity for strategic growth, reinforcing confidence among stakeholders and potential investors.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years